[{"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-001", "question": "A 58-year-old woman with hypertrophic cardiomyopathy presents with progressive dyspnea and New York Heart Association class III symptoms despite maximum tolerated doses of metoprolol and verapamil. Echocardiography reveals a resting left ventricular outflow tract (LVOT) gradient of 85 mmHg, septal thickness of 22 mm, and systolic anterior motion of the mitral valve with moderate mitral regurgitation. She has no coronary artery disease on angiography. The septal perforator anatomy is suitable for intervention. Which of the following findings would most strongly favor surgical myectomy over alcohol septal ablation in this patient?", "options": ["Concomitant intrinsic mitral valve disease requiring repair", "Patient preference for less invasive procedure", "Presence of atrial fibrillation requiring maze procedure consideration", "Septal thickness greater than 20 mm", "Age greater than 55 years"], "answer": "A", "answer_index": 0, "explanation": "Surgical myectomy is preferred over alcohol septal ablation when concomitant cardiac pathology requiring surgical correction exists, such as intrinsic mitral valve disease (leaflet abnormalities, chordal pathology) needing repair or replacement. While septal thickness >30mm and unsuitable coronary anatomy favor surgery, 22mm thickness alone does not preclude ablation. Atrial fibrillation can be addressed with catheter ablation. Age and patient preference, while considerations, are not absolute indications for one approach over another.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The patient meets indications for septal reduction therapy (severe symptoms despite medical therapy, high gradient). The choice between surgical myectomy and alcohol septal ablation (ASA) is driven by specific clinical factors. According to ACC/AHA guidelines, the presence of concomitant intrinsic mitral valve disease requiring repair (Option A) is a Class I indication to prefer surgery, as myectomy can be combined with valve repair/replacement, whereas ASA cannot address intrinsic valve pathology. Option B favors ASA (less invasive). Option C (AF) is a consideration for surgical Maze, but AF can often be managed via catheter ablation, making it a less absolute indication for open surgery than structural valve disease. Option D is incorrect; septal thickness >30 mm favors surgery, but 22 mm is suitable for either. Option E is incorrect; older age generally favors ASA or is neutral, whereas younger age favors surgery. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The patient meets indications for septal reduction therapy (severe symptoms despite medical therapy, high gradient). The choice between surgical myectomy and alcohol septal ablation (ASA) is driven by specific clinical factors. According to ACC/AHA guidelines, the presence of concomitant intrinsic mitral valve disease requiring repair (Option A) is a Class I indication to prefer surgery, as myectomy can be combined with valve repair/replacement, whereas ASA cannot address intrinsic valve pathology. Option B favors ASA (less invasive). Option C (AF) is a consideration for surgical Maze, but AF can often be managed via catheter ablation, making it a less absolute indication for open surgery than structural valve disease. Option D is incorrect; septal thickness >30 mm favors surgery, but 22 mm is suitable for either. Option E is incorrect; older age generally favors ASA or is neutral, whereas younger age favors surgery. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-002", "question": "A 6-year-old boy presents with recurrent episodes of weakness and dark urine following viral illnesses. Laboratory studies during an acute episode show: serum creatine kinase 45,000 U/L, myoglobinuria, and non-ketotic hypoglycemia with inappropriately low free fatty acids. Acylcarnitine profile shows elevated C14:1 and C14:2 species. Genetic testing confirms compound heterozygous mutations in ACADVL. Which of the following dietary modifications is most critical for preventing future metabolic crises?", "options": ["Strict avoidance of medium-chain triglycerides", "Supplementation with odd-chain fatty acids", "Restriction of long-chain fatty acids with medium-chain triglyceride supplementation", "High-protein diet with branched-chain amino acid supplementation", "Carnitine supplementation with unrestricted fat intake"], "answer": "C", "answer_index": 2, "explanation": "ACADVL mutations cause very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency, a disorder of long-chain fatty acid oxidation. Management requires restriction of long-chain fatty acids (which cannot be metabolized) and supplementation with medium-chain triglycerides (MCTs), which bypass the defective enzyme and provide an alternative energy source. MCT avoidance would be harmful. Carnitine supplementation alone without dietary modification is insufficient, and high-protein diets do not address the underlying metabolic defect.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic case of Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency, evidenced by rhabdomyolysis, non-ketotic hypoglycemia, specific acylcarnitine elevations (C14:1), and confirmed *ACADVL* mutations. The question asks for the primary dietary management. Option C is the correct best answer: management involves restricting long-chain fatty acids (to prevent accumulation of toxic intermediates) and supplementing with medium-chain triglycerides (MCTs), which bypass the enzymatic defect and provide energy. Option A is incorrect as MCTs are the treatment, not the trigger. Option B (odd-chain fatty acids, e.g., triheptanoin) is a valid therapy for LC-FAODs, but Option C is the better 'best answer' because it explicitly includes the critical component of LCT restriction, which is fundamental to preventing crises. Option E is dangerous due to unrestricted fat intake. Note: The stem mentions 'inappropriately low free fatty acids' during hypoglycemia; typically, FAODs present with high free fatty acids and low ketones (hypoketotic hypoglycemia). Low FFAs would suggest hyperinsulinism. However, the explicit genetic and acylcarnitine data confirm VLCAD, making the diagnosis unambiguous despite this minor biochemical inconsistency.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic case of Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency, evidenced by rhabdomyolysis, non-ketotic hypoglycemia, specific acylcarnitine elevations (C14:1), and confirmed *ACADVL* mutations. The question asks for the primary dietary management. Option C is the correct best answer: management involves restricting long-chain fatty acids (to prevent accumulation of toxic intermediates) and supplementing with medium-chain triglycerides (MCTs), which bypass the enzymatic defect and provide energy. Option A is incorrect as MCTs are the treatment, not the trigger. Option B (odd-chain fatty acids, e.g., triheptanoin) is a valid therapy for LC-FAODs, but Option C is the better 'best answer' because it explicitly includes the critical component of LCT restriction, which is fundamental to preventing crises. Option E is dangerous due to unrestricted fat intake. Note: The stem mentions 'inappropriately low free fatty acids' during hypoglycemia; typically, FAODs present with high free fatty acids and low ketones (hypoketotic hypoglycemia). Low FFAs would suggest hyperinsulinism. However, the explicit genetic and acylcarnitine data confirm VLCAD, making the diagnosis unambiguous despite this minor biochemical inconsistency.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-003", "question": "A 34-year-old woman with systemic lupus erythematosus on hydroxychloroquine and mycophenolate presents with acute onset severe headache, confusion, and seizures. Blood pressure is 168/102 mmHg. MRI brain shows bilateral posterior white matter T2/FLAIR hyperintensities without restricted diffusion. Lumbar puncture shows normal opening pressure, 8 WBC/μL (lymphocyte predominant), protein 52 mg/dL, and negative cultures. Anti-ribosomal P antibodies are positive. Which additional finding would most strongly suggest neuropsychiatric lupus rather than posterior reversible encephalopathy syndrome (PRES)?", "options": ["Presence of anti-dsDNA antibodies at high titer", "Low complement C3 and C4 levels", "Elevated CSF IgG index with oligoclonal bands", "Resolution of MRI findings with blood pressure control", "Concurrent lupus nephritis flare"], "answer": "C", "answer_index": 2, "explanation": "Elevated CSF IgG index with oligoclonal bands indicates intrathecal immunoglobulin synthesis, strongly supporting CNS inflammation from neuropsychiatric lupus (NPSLE) rather than PRES, which is a vasogenic edema syndrome without primary CNS inflammation. Anti-dsDNA antibodies and low complements indicate systemic lupus activity but don't differentiate CNS involvement. Resolution with BP control would actually favor PRES. Concurrent nephritis indicates systemic activity but doesn't confirm CNS-specific disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic diagnostic dilemma: distinguishing Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) from Posterior Reversible Encephalopathy Syndrome (PRES) in an SLE patient with hypertension and seizures. The MRI findings (posterior T2/FLAIR hyperintensities) strongly favor PRES, but the question asks for a finding that would shift the diagnosis toward NPSLE. Options A, B, and E indicate systemic lupus activity; while NPSLE occurs during active disease, active disease (especially nephritis) also causes hypertension and renal failure, which are the primary drivers of PRES. Thus, systemic markers do not reliably discriminate. Option D (resolution with BP control) confirms PRES. Option C (Elevated CSF IgG index/oligoclonal bands) indicates intrathecal inflammation/antibody synthesis. PRES is a phenomenon of vasogenic edema due to autoregulatory failure, not primary CNS inflammation, and typically has normal CSF immunology. Therefore, the presence of oligoclonal bands is the strongest specific evidence for an inflammatory CNS process (NPSLE) over a hemodynamic one (PRES). The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic diagnostic dilemma: distinguishing Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) from Posterior Reversible Encephalopathy Syndrome (PRES) in an SLE patient with hypertension and seizures. The MRI findings (posterior T2/FLAIR hyperintensities) strongly favor PRES, but the question asks for a finding that would shift the diagnosis toward NPSLE. Options A, B, and E indicate systemic lupus activity; while NPSLE occurs during active disease, active disease (especially nephritis) also causes hypertension and renal failure, which are the primary drivers of PRES. Thus, systemic markers do not reliably discriminate. Option D (resolution with BP control) confirms PRES. Option C (Elevated CSF IgG index/oligoclonal bands) indicates intrathecal inflammation/antibody synthesis. PRES is a phenomenon of vasogenic edema due to autoregulatory failure, not primary CNS inflammation, and typically has normal CSF immunology. Therefore, the presence of oligoclonal bands is the strongest specific evidence for an inflammatory CNS process (NPSLE) over a hemodynamic one (PRES). The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-004", "question": "A 52-year-old man with type 2 diabetes presents for evaluation of recurrent hypoglycemia occurring 3-4 hours postprandially. He underwent Roux-en-Y gastric bypass 2 years ago with 45 kg weight loss. During a symptomatic episode, laboratory studies show: glucose 38 mg/dL, insulin 45 μU/mL (elevated), C-peptide 8.2 ng/mL (elevated), proinsulin 22 pmol/L (elevated), and negative sulfonylurea screen. Calcium-stimulated angiography localizes insulin secretion to the body and tail of the pancreas. Which of the following is the most appropriate next step in management?", "options": ["Distal pancreatectomy", "Diazoxide therapy", "Octreotide therapy", "Dietary modification with acarbose", "Enucleation of insulinoma"], "answer": "D", "answer_index": 3, "explanation": "This presentation is classic for post-gastric bypass hyperinsulinemic hypoglycemia (nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome). Unlike insulinoma, this involves diffuse islet cell hyperfunction. First-line management is dietary modification (low glycemic index, frequent small meals) combined with acarbose to slow carbohydrate absorption and blunt the exaggerated incretin response. Distal pancreatectomy is reserved for refractory cases. The diffuse localization on angiography and post-bypass context argue against focal insulinoma requiring enucleation.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic case of post-bariatric hypoglycemia (PBH), also known as non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS), characterized by postprandial neuroglycopenia and hyperinsulinemic hypoglycemia following Roux-en-Y gastric bypass. The laboratory findings (elevated insulin, C-peptide, proinsulin; negative sulfonylurea) confirm endogenous hyperinsulinism. The calcium-stimulated angiography localizing secretion to the body and tail helps rule out diffuse involvement of the head (which would complicate surgical planning) and supports a pancreatic source, but the history strongly favors PBH over a sporadic insulinoma. The standard of care for PBH is a stepwise approach. First-line management is strictly medical: dietary modification (low glycemic index, controlled portions) and acarbose to blunt glucose excursions. Surgical intervention (distal pancreatectomy) is reserved for patients refractory to medical therapy due to significant morbidity and variable success rates. Although the presence of invasive calcium-stimulated angiography typically implies that medical management has already failed (as this test is usually for surgical planning), in the context of a board exam 'next step' question without explicit mention of failed prior therapy, the examinee must select the standard first-line treatment. Therefore, Option D is the unique best answer. Option A is a later-stage intervention. Option E treats insulinoma, which is less likely given the bypass history and regional localization.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic case of post-bariatric hypoglycemia (PBH), also known as non-insulinoma pancreatogenous hypoglycemia syndrome (NIPHS), characterized by postprandial neuroglycopenia and hyperinsulinemic hypoglycemia following Roux-en-Y gastric bypass. The laboratory findings (elevated insulin, C-peptide, proinsulin; negative sulfonylurea) confirm endogenous hyperinsulinism. The calcium-stimulated angiography localizing secretion to the body and tail helps rule out diffuse involvement of the head (which would complicate surgical planning) and supports a pancreatic source, but the history strongly favors PBH over a sporadic insulinoma. The standard of care for PBH is a stepwise approach. First-line management is strictly medical: dietary modification (low glycemic index, controlled portions) and acarbose to blunt glucose excursions. Surgical intervention (distal pancreatectomy) is reserved for patients refractory to medical therapy due to significant morbidity and variable success rates. Although the presence of invasive calcium-stimulated angiography typically implies that medical management has already failed (as this test is usually for surgical planning), in the context of a board exam 'next step' question without explicit mention of failed prior therapy, the examinee must select the standard first-line treatment. Therefore, Option D is the unique best answer. Option A is a later-stage intervention. Option E treats insulinoma, which is less likely given the bypass history and regional localization.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-005", "question": "A 3-week-old male infant presents with poor feeding, lethargy, and hypotonia. He was born at term following an uncomplicated pregnancy. Physical examination reveals hepatomegaly, hypotonia, and macroglossia. Echocardiography shows severe biventricular hypertrophy with a left ventricular ejection fraction of 25%. Laboratory studies show elevated creatine kinase and AST. Urine organic acids are normal. Enzyme assay on dried blood spot shows markedly reduced acid alpha-glucosidase activity. Genetic testing confirms two pathogenic variants in GAA. Which of the following factors is most predictive of poor response to enzyme replacement therapy?", "options": ["Presence of cardiomyopathy at diagnosis", "Cross-reactive immunologic material (CRIM) negative status", "Age at diagnosis less than 1 month", "Elevated creatine kinase level", "Presence of macroglossia"], "answer": "B", "answer_index": 1, "explanation": "In infantile-onset Pompe disease, CRIM-negative status (complete absence of endogenous GAA protein) is the strongest predictor of poor response to enzyme replacement therapy (ERT) due to development of high-sustained antibody titers against the recombinant enzyme, which neutralize therapeutic effect. CRIM-negative patients require immune tolerance induction protocols. While early cardiomyopathy and young age at diagnosis indicate severe disease, CRIM-positive patients with these features can still respond well to ERT. Elevated CK and macroglossia are disease markers but not predictive of treatment response.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict on keyed answer: Correct best. The vignette accurately depicts infantile-onset Pompe disease (IOPD) with characteristic features: hypotonia, macroglossia, hepatomegaly, and severe hypertrophic cardiomyopathy. The question correctly identifies Cross-Reactive Immunologic Material (CRIM) negative status (Option B) as the most significant predictor of poor clinical response to Enzyme Replacement Therapy (ERT). CRIM-negative patients lack endogenous GAA protein, causing the immune system to recognize the recombinant enzyme as foreign. This triggers high-titer neutralizing antibodies that abrogate the therapy's efficacy, leading to clinical failure and death unless immune tolerance induction is administered. While severe cardiomyopathy (Option A) is a marker of disease progression, ERT can reverse cardiac hypertrophy in CRIM-positive patients; thus, CRIM status is the upstream determinant of reversibility. Age < 1 month (Option C) correlates with severity but is not a mechanism of treatment resistance. Options D and E are diagnostic features, not prognostic of therapeutic response. The item is logically sound, medically precise, and aligns with current consensus guidelines for IOPD management.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The vignette accurately depicts infantile-onset Pompe disease (IOPD) with characteristic features: hypotonia, macroglossia, hepatomegaly, and severe hypertrophic cardiomyopathy. The question correctly identifies Cross-Reactive Immunologic Material (CRIM) negative status (Option B) as the most significant predictor of poor clinical response to Enzyme Replacement Therapy (ERT). CRIM-negative patients lack endogenous GAA protein, causing the immune system to recognize the recombinant enzyme as foreign. This triggers high-titer neutralizing antibodies that abrogate the therapy's efficacy, leading to clinical failure and death unless immune tolerance induction is administered. While severe cardiomyopathy (Option A) is a marker of disease progression, ERT can reverse cardiac hypertrophy in CRIM-positive patients; thus, CRIM status is the upstream determinant of reversibility. Age < 1 month (Option C) correlates with severity but is not a mechanism of treatment resistance. Options D and E are diagnostic features, not prognostic of therapeutic response. The item is logically sound, medically precise, and aligns with current consensus guidelines for IOPD management.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-006", "question": "A 67-year-old man with ischemic cardiomyopathy (LVEF 28%) and an implantable cardioverter-defibrillator presents after receiving three appropriate shocks for ventricular tachycardia over 24 hours despite amiodarone 400 mg daily. He is hemodynamically stable with blood pressure 102/68 mmHg. ECG shows sinus rhythm at 72 bpm with QTc 485 ms. Electrolytes and thyroid function are normal. Device interrogation confirms monomorphic VT at 188 bpm terminated by ATP and shocks. Which of the following is the most appropriate next step?", "options": ["Increase amiodarone to 600 mg daily", "Add mexiletine 200 mg three times daily", "Urgent catheter ablation of ventricular tachycardia", "Initiate dofetilide after appropriate QTc assessment", "Add ranolazine 500 mg twice daily"], "answer": "C", "answer_index": 2, "explanation": "This patient has electrical storm (≥3 sustained VT/VF episodes in 24 hours) refractory to amiodarone, which is a class I indication for urgent catheter ablation per current guidelines. Increasing amiodarone risks toxicity and QT prolongation. Adding mexiletine is reasonable for adjunctive therapy but does not address the substrate. Dofetilide is contraindicated with QTc >440ms in men and in the acute setting. Ranolazine has limited evidence for VT suppression. Catheter ablation targeting the VT substrate offers the best chance of preventing recurrent episodes.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a patient with ischemic cardiomyopathy and an ICD presenting with electrical storm (defined as ≥3 episodes of sustained VT/VF in 24 hours) despite maintenance amiodarone therapy. The patient is hemodynamically stable but represents a high-risk scenario. According to the 2017 AHA/ACC/HRS guidelines, catheter ablation is a Class I recommendation for patients with ischemic cardiomyopathy and recurrent sustained monomorphic VT despite antiarrhythmic drug therapy. While adding mexiletine (Option B) is a clinically valid adjunctive pharmacologic strategy to suppress immediate ectopy, catheter ablation is the definitive treatment for drug-refractory VT and is superior in hierarchy for 'next step' management questions regarding electrical storm. Increasing amiodarone (Option A) is unlikely to be effective given the failure at 400 mg and risks toxicity. Dofetilide (Option D) is contraindicated for initiation because the QTc is 485 ms (limit is typically 440 ms). Ranolazine (Option E) has weak evidence compared to ablation. Thus, Option C is the unique best answer supported by guidelines.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a patient with ischemic cardiomyopathy and an ICD presenting with electrical storm (defined as ≥3 episodes of sustained VT/VF in 24 hours) despite maintenance amiodarone therapy. The patient is hemodynamically stable but represents a high-risk scenario. According to the 2017 AHA/ACC/HRS guidelines, catheter ablation is a Class I recommendation for patients with ischemic cardiomyopathy and recurrent sustained monomorphic VT despite antiarrhythmic drug therapy. While adding mexiletine (Option B) is a clinically valid adjunctive pharmacologic strategy to suppress immediate ectopy, catheter ablation is the definitive treatment for drug-refractory VT and is superior in hierarchy for 'next step' management questions regarding electrical storm. Increasing amiodarone (Option A) is unlikely to be effective given the failure at 400 mg and risks toxicity. Dofetilide (Option D) is contraindicated for initiation because the QTc is 485 ms (limit is typically 440 ms). Ranolazine (Option E) has weak evidence compared to ablation. Thus, Option C is the unique best answer supported by guidelines.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-007", "question": "A 14-year-old girl presents with 6 months of progressive proximal muscle weakness, heliotrope rash, and Gottron papules. She has difficulty climbing stairs and raising her arms. Laboratory studies show CK 4,200 U/L and positive anti-MDA5 antibodies. Chest CT reveals subtle ground-glass opacities in bilateral lower lobes. Pulmonary function tests show FVC 72% predicted and DLCO 58% predicted. Muscle biopsy shows perifascicular atrophy. Which of the following findings most significantly increases her risk of rapidly progressive interstitial lung disease?", "options": ["Elevated serum ferritin level", "Presence of mechanic's hands", "Positive anti-Jo-1 antibodies", "Calcinosis cutis on examination", "Elevated aldolase level"], "answer": "A", "answer_index": 0, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is associated with rapidly progressive interstitial lung disease (RP-ILD), which can be fatal. Elevated serum ferritin is a biomarker strongly associated with RP-ILD severity and poor prognosis in anti-MDA5 positive patients, reflecting macrophage activation. Anti-Jo-1 is associated with ILD but typically a more chronic course. Mechanic's hands are associated with antisynthetase syndrome. Calcinosis and elevated aldolase are features of juvenile DM but not specific predictors of RP-ILD in anti-MDA5 disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Correct best answer. The vignette describes a classic case of Juvenile Dermatomyositis (JDM) with anti-MDA5 antibodies and early interstitial lung disease (ILD). Anti-MDA5 dermatomyositis is distinctively associated with a high risk of Rapidly Progressive ILD (RP-ILD), which carries high mortality. Among the options provided, elevated serum ferritin (Option A) is a well-established, critical biomarker for RP-ILD severity and poor prognosis in anti-MDA5 patients, often reflecting a hyper-inflammatory state or macrophage activation. Option C (Anti-Jo-1) is typically mutually exclusive with anti-MDA5 and is associated with Antisynthetase Syndrome, where ILD is common but usually follows a more chronic/subacute course rather than the fulminant RP-ILD of MDA5. Mechanic's hands (Option B) are a clinical feature of antisynthetase syndrome (and sometimes MDA5) but do not independently predict the *rapidity* or severity of ILD progression like ferritin does. Calcinosis (Option D) and Aldolase (Option E) are general features of JDM but not specific predictors of RP-ILD. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Correct best answer. The vignette describes a classic case of Juvenile Dermatomyositis (JDM) with anti-MDA5 antibodies and early interstitial lung disease (ILD). Anti-MDA5 dermatomyositis is distinctively associated with a high risk of Rapidly Progressive ILD (RP-ILD), which carries high mortality. Among the options provided, elevated serum ferritin (Option A) is a well-established, critical biomarker for RP-ILD severity and poor prognosis in anti-MDA5 patients, often reflecting a hyper-inflammatory state or macrophage activation. Option C (Anti-Jo-1) is typically mutually exclusive with anti-MDA5 and is associated with Antisynthetase Syndrome, where ILD is common but usually follows a more chronic/subacute course rather than the fulminant RP-ILD of MDA5. Mechanic's hands (Option B) are a clinical feature of antisynthetase syndrome (and sometimes MDA5) but do not independently predict the *rapidity* or severity of ILD progression like ferritin does. Calcinosis (Option D) and Aldolase (Option E) are general features of JDM but not specific predictors of RP-ILD. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-008", "question": "A 42-year-old woman presents to the emergency department with acute chest pain and dyspnea. She has a history of antiphospholipid syndrome with prior deep vein thrombosis, currently on warfarin with INR 2.8. ECG shows sinus tachycardia with new right bundle branch block. CT pulmonary angiography reveals bilateral pulmonary emboli with right ventricular dilation. Troponin I is 0.89 ng/mL. Blood pressure is 88/54 mmHg, heart rate 118 bpm. Despite 2 liters of crystalloid, blood pressure remains 84/52 mmHg. Which of the following is the most appropriate next step?", "options": ["Initiate unfractionated heparin infusion", "Administer systemic alteplase", "Perform catheter-directed thrombolysis", "Emergent surgical embolectomy", "Initiate norepinephrine and observe"], "answer": "B", "answer_index": 1, "explanation": "This patient has high-risk (massive) pulmonary embolism with hemodynamic instability (persistent hypotension despite fluid resuscitation) and RV dysfunction. Systemic thrombolysis with alteplase is the first-line treatment for hemodynamically unstable PE per guidelines, even in anticoagulated patients, as the mortality benefit outweighs bleeding risk. The therapeutic INR does not preclude thrombolysis in this life-threatening situation. Catheter-directed therapy or surgical embolectomy are alternatives if thrombolysis is contraindicated or fails. Simply adding vasopressors without addressing the obstruction is inadequate.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient presents with massive (high-risk) pulmonary embolism, defined by sustained hypotension (BP <90 mmHg) and right ventricular dysfunction. The standard of care for massive PE is immediate reperfusion. Systemic thrombolysis (Option B) is the first-line reperfusion therapy recommended by major guidelines (e.g., ESC, AHA, CHEST) for unstable patients, as it offers the most rapid restoration of pulmonary perfusion. While the patient is on warfarin with a therapeutic INR of 2.8, current oral anticoagulation is generally considered a relative, not absolute, contraindication to thrombolysis in the setting of life-threatening high-risk PE. The immediate mortality risk from obstructive shock typically outweighs the bleeding risk. Surgical embolectomy (Option D) and catheter-directed therapies (Option C) are appropriate alternatives if thrombolysis is absolutely contraindicated or fails, but they require specific resources and setup time that may not be immediately available. Given the urgency of the hypotension, systemic alteplase is the most appropriate *immediate* next step. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient presents with massive (high-risk) pulmonary embolism, defined by sustained hypotension (BP <90 mmHg) and right ventricular dysfunction. The standard of care for massive PE is immediate reperfusion. Systemic thrombolysis (Option B) is the first-line reperfusion therapy recommended by major guidelines (e.g., ESC, AHA, CHEST) for unstable patients, as it offers the most rapid restoration of pulmonary perfusion. While the patient is on warfarin with a therapeutic INR of 2.8, current oral anticoagulation is generally considered a relative, not absolute, contraindication to thrombolysis in the setting of life-threatening high-risk PE. The immediate mortality risk from obstructive shock typically outweighs the bleeding risk. Surgical embolectomy (Option D) and catheter-directed therapies (Option C) are appropriate alternatives if thrombolysis is absolutely contraindicated or fails, but they require specific resources and setup time that may not be immediately available. Given the urgency of the hypotension, systemic alteplase is the most appropriate *immediate* next step. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-009", "question": "A 28-year-old woman with Graves' disease treated with methimazole 30 mg daily for 8 weeks presents with fever (39.2°C), severe sore throat, and malaise for 2 days. Physical examination reveals pharyngeal erythema without exudate and no lymphadenopathy. Complete blood count shows WBC 1,200/μL with absolute neutrophil count 80/μL, hemoglobin 13.2 g/dL, and platelets 245,000/μL. Which of the following is the most appropriate immediate management?", "options": ["Discontinue methimazole and initiate propylthiouracil", "Discontinue methimazole, obtain blood cultures, and initiate broad-spectrum antibiotics with G-CSF", "Continue methimazole at reduced dose with close monitoring", "Discontinue methimazole and proceed with urgent thyroidectomy", "Discontinue methimazole and initiate lithium carbonate"], "answer": "B", "answer_index": 1, "explanation": "This patient has methimazole-induced agranulocytosis (ANC <500/μL), a rare but life-threatening complication occurring in 0.1-0.5% of patients, typically within the first 3 months. Management requires immediate discontinuation of the offending thionamide (cross-reactivity precludes switching to PTU), blood cultures, broad-spectrum antibiotics covering Pseudomonas given febrile neutropenia, and G-CSF to accelerate neutrophil recovery. Continuing or reducing methimazole is dangerous. Urgent thyroidectomy in an agranulocytic patient carries prohibitive infection risk. Alternative thyroid control can be achieved with beta-blockers, iodine, or lithium after stabilization.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best. Key stem clues: Patient on methimazole for 8 weeks presents with fever, sore throat, and severe neutropenia (ANC 80/μL), diagnostic of drug-induced agranulocytosis with febrile neutropenia. Evaluation: The immediate priority is managing the life-threatening infection risk and stopping the causative agent. Option B correctly lists discontinuation of methimazole, sepsis workup (cultures), broad-spectrum antibiotics, and G-CSF (often recommended to shorten recovery time in this context). Option A is incorrect because cross-reactivity between methimazole and propylthiouracil is high regarding agranulocytosis. Option C is dangerous. Option D is contraindicated due to the extreme surgical risk in an untreated neutropenic, septic patient. Option E fails to address the immediate infectious emergency. The item is medically accurate and logically sound, adhering to standard guidelines (e.g., ATA). Minimal fix: None required.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best. Key stem clues: Patient on methimazole for 8 weeks presents with fever, sore throat, and severe neutropenia (ANC 80/μL), diagnostic of drug-induced agranulocytosis with febrile neutropenia. Evaluation: The immediate priority is managing the life-threatening infection risk and stopping the causative agent. Option B correctly lists discontinuation of methimazole, sepsis workup (cultures), broad-spectrum antibiotics, and G-CSF (often recommended to shorten recovery time in this context). Option A is incorrect because cross-reactivity between methimazole and propylthiouracil is high regarding agranulocytosis. Option C is dangerous. Option D is contraindicated due to the extreme surgical risk in an untreated neutropenic, septic patient. Option E fails to address the immediate infectious emergency. The item is medically accurate and logically sound, adhering to standard guidelines (e.g., ATA). Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-010", "question": "A 9-year-old boy with a history of Kawasaki disease at age 2 (treated with IVIG and aspirin, with documented giant coronary artery aneurysms) presents for routine cardiology follow-up. He is asymptomatic and active without limitations. Current medications include aspirin 81 mg daily and clopidogrel 75 mg daily. Echocardiography shows a 9 mm right coronary artery aneurysm (z-score +12) and 7 mm left anterior descending aneurysm (z-score +9). Stress MRI perfusion shows no inducible ischemia. Which of the following additional interventions is most strongly recommended based on current guidelines?", "options": ["Addition of warfarin with target INR 2.0-3.0", "Discontinuation of clopidogrel given no ischemia", "Annual exercise stress testing only", "Coronary CT angiography every 5 years", "Restriction from all competitive sports"], "answer": "A", "answer_index": 0, "explanation": "Giant coronary artery aneurysms (z-score ≥10 or absolute diameter ≥8mm) represent the highest risk category in Kawasaki disease and require triple antithrombotic therapy: aspirin, a second antiplatelet agent (clopidogrel), AND systemic anticoagulation with warfarin (target INR 2.0-3.0) or LMWH per AHA guidelines. This is due to high thrombotic risk within aneurysms. The absence of current ischemia does not reduce thrombotic risk. These patients require activity restriction from contact/collision sports but the antithrombotic intensification is the most critical missing intervention.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with Kawasaki disease and a Giant Coronary Artery Aneurysm (RCA 9mm, z-score +12), classifying him as Risk Level 5 per AHA guidelines. The standard of care for Giant Aneurysms includes systemic anticoagulation (e.g., warfarin) in addition to low-dose aspirin to prevent thrombosis. The patient is currently on dual antiplatelet therapy (aspirin + clopidogrel) but lacks anticoagulation. Option A correctly identifies the need to add warfarin. While the explanation states 'triple therapy' is required, guidelines typically recommend Aspirin + Warfarin, with Triple Therapy (Aspirin + Clopidogrel + Warfarin) reserved for very high-risk cases; however, given the choices, Option A is the only one that establishes the necessary anticoagulation. Option B (stopping clopidogrel) would leave the patient on aspirin alone, which is insufficient. Option E is incorrect because patients with no ischemia are typically restricted only from collision/contact sports, not all competitive sports. Options C and D suggest insufficient monitoring frequencies. The item is logically valid as Option A is the clear best answer among the distractors.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with Kawasaki disease and a Giant Coronary Artery Aneurysm (RCA 9mm, z-score +12), classifying him as Risk Level 5 per AHA guidelines. The standard of care for Giant Aneurysms includes systemic anticoagulation (e.g., warfarin) in addition to low-dose aspirin to prevent thrombosis. The patient is currently on dual antiplatelet therapy (aspirin + clopidogrel) but lacks anticoagulation. Option A correctly identifies the need to add warfarin. While the explanation states 'triple therapy' is required, guidelines typically recommend Aspirin + Warfarin, with Triple Therapy (Aspirin + Clopidogrel + Warfarin) reserved for very high-risk cases; however, given the choices, Option A is the only one that establishes the necessary anticoagulation. Option B (stopping clopidogrel) would leave the patient on aspirin alone, which is insufficient. Option E is incorrect because patients with no ischemia are typically restricted only from collision/contact sports, not all competitive sports. Options C and D suggest insufficient monitoring frequencies. The item is logically valid as Option A is the clear best answer among the distractors.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]